Final Written Decision: original | Apr 10, 2023 | PAPER | BOARD |
Petitioner's Updated Mandatory Notice | Apr 4, 2023 | PAPER | PETITIONER |
Other: Hearing transcript | Mar 14, 2023 | PAPER | BOARD |
EXPUNGED | Feb 3, 2023 | PAPER | PETITIONER |
Petitioner Bausch's Demonstrative Slides | Feb 3, 2023 | EXHIBIT | PETITIONER |
Petitioner's Updated Mandatory Notice | Jan 23, 2023 | PAPER | PETITIONER |
Order: Conduct of the Proceeding - 37 CFR 42.5 | Jan 6, 2023 | PAPER | BOARD |
Ex. 3003 | Jan 6, 2023 | EXHIBIT | BOARD |
EXPUNGED | Jan 4, 2023 | PAPER | BOARD |
EXPUNGED | Jan 4, 2023 | PAPER | BOARD |
ORDER Setting Oral Argument 37 C.F.R. § 42.70 | Jan 4, 2023 | PAPER | BOARD |
Petitioner's Objections to Patent Owner Exhibit | Dec 16, 2022 | PAPER | PETITIONER |
Patent Owner's Surreply | Dec 9, 2022 | PAPER | PATENT OWNER |
EXPUNGED | Dec 9, 2022 | EXHIBIT | PATENT OWNER |
Bausch Request for Oral Argument | Dec 5, 2022 | PAPER | PETITIONER |
Ex. 3002 PTAB Response 11/22 | Nov 23, 2022 | EXHIBIT | BOARD |
Ex. 3001 Attorney Correspondence 11/15 | Nov 23, 2022 | EXHIBIT | BOARD |
Order: Revised Scheduling Order | Nov 23, 2022 | PAPER | BOARD |
Order: Conduct of the Proceeding - 37 CFR 42.5 | Nov 7, 2022 | PAPER | BOARD |
Petitioner's Updated Mandatory Notice | Oct 28, 2022 | PAPER | PETITIONER |
Bausch Reply to Patent Owner Response | Oct 28, 2022 | PAPER | PETITIONER |
’133 Patent Application Data Sheet | Oct 28, 2022 | EXHIBIT | PETITIONER |
’431 Patent Application Data Sheet | Oct 28, 2022 | EXHIBIT | PETITIONER |
Pending 16/949,955 Application Data Sheet | Oct 28, 2022 | EXHIBIT | PETITIONER |
Pending 17/656,825 Application Data Sheet | Oct 28, 2022 | EXHIBIT | PETITIONER |
’133 Patent Filing Receipt | Oct 28, 2022 | EXHIBIT | PETITIONER |
Pending 16/949,955 Filing Receipt | Oct 28, 2022 | EXHIBIT | PETITIONER |
Pending 17/656,825 Filing Receipt | Oct 28, 2022 | EXHIBIT | PETITIONER |
’431 Patent Filing Receipt | Oct 28, 2022 | EXHIBIT | PETITIONER |
Deposition Transcript of Dr. Dennis Gierhart, October 18, 2022 | Oct 28, 2022 | EXHIBIT | PETITIONER |
Deposition Transcript of Dr. C. Kathleen Dorey, Oct. 4, 2022 | Oct 28, 2022 | EXHIBIT | PETITIONER |
DONALD P. GOLDBERG, ET AL., THE BEST SUPPLEMENTS FOR YOUR HEALTH (2002) (Dorey Exhibit 5) | Oct 28, 2022 | EXHIBIT | PETITIONER |
Ivy Greenwell, Newly Discovered Benefits of Gamma Tocopherol, LIFE EXTENSION 38 (2002) (Dorey Exhibit 7) | Oct 28, 2022 | EXHIBIT | PETITIONER |
Qing Jiang, et al., Gamma-Tocopherol, the major form of vitamin E in the US diet, deserves more attention, 74 AM. J. CLIN. NUTR. 714 (2001) (Dorey Exhibit 8) | Oct 28, 2022 | EXHIBIT | PETITIONER |
Barbara J. Lyle, et al., Serum carotenoids and tocopherols and incidence of age-related nuclear cataract, 69 AM. J. CLIN. NUTR. 272 (1999) (Dorey Exhibit 6) | Oct 28, 2022 | EXHIBIT | PETITIONER |
Dorey Exhibit 3 from Cross-Examination of Dr. C. Kathleen Dorey, October 4, 2022 | Oct 28, 2022 | EXHIBIT | PETITIONER |
Bausch Notice of Deposition of Dr. Gierhart | Oct 3, 2022 | PAPER | PETITIONER |
JOINT NOTICE OF STIPULATION TO CHANGE DUE DATES | Sep 21, 2022 | PAPER | PETITIONER |
ORDER Granting Petitioners Motions for Pro Hac Vice Admission of Monica Chou and Steven C. Kline 37 C.F.R. sec 42.10 | Sep 20, 2022 | PAPER | BOARD |
Bausch Notice of Deposition of Dr Dorey | Sep 20, 2022 | PAPER | PETITIONER |
PETITIONERS MOTION FOR ADMISSION PRO HAC VICE OF STEVEN C. KLINE | Sep 7, 2022 | PAPER | PETITIONER |
EXPUNGED | Sep 6, 2022 | PAPER | PETITIONER |
PETITIONERS MOTION FOR ADMISSION PRO HAC VICE OF MONICA CHOU | Sep 6, 2022 | PAPER | PETITIONER |
DECLARATION OF STEVEN C. KLINE IN SUPPORT OF MOTION FOR ADMISSION PRO HAC VICE | Sep 6, 2022 | EXHIBIT | PETITIONER |
DECLARATION OF MONICA CHOU IN SUPPORT OF MOTION FOR ADMISSION PRO HAC VICE | Sep 6, 2022 | EXHIBIT | PETITIONER |
Petitioner's Updated Exhibit List | Aug 31, 2022 | PAPER | PETITIONER |
Patent Owner's Response to Petition | Jul 11, 2022 | PAPER | PATENT OWNER |
Supplemental Declaration of Dr. C. Kathleen Dorey, Ph.D. | Jul 11, 2022 | EXHIBIT | PATENT OWNER |
United States Patent and Trademark Office, Decision on Appeal No. 2013-000129 | Jul 11, 2022 | EXHIBIT | PATENT OWNER |
Effect of Zeaxanthin and Antioxidant Supplementation on Vascular Endothelial Growth Factor (VEGF) Expression in Apolipoprotein-E Deficient Mice, Fern��ndez-Robredo et al | Jul 11, 2022 | EXHIBIT | PATENT OWNER |
Declaration of Dr. Dennis Gierhart | Jul 11, 2022 | EXHIBIT | PATENT OWNER |
Order: Corrected Scheduling Order | May 13, 2022 | PAPER | BOARD |
Institution Decision: Grant | Apr 18, 2022 | PAPER | BOARD |
Order: Scheduling Order | Apr 18, 2022 | PAPER | BOARD |
Patent Owner's Preliminary Response | Jan 21, 2022 | PAPER | PATENT OWNER |
Declaration of Dr. C. Kathleen Dorey with CV | Jan 21, 2022 | EXHIBIT | PATENT OWNER |
Patent Owner's Mandatory Notice | Dec 10, 2021 | PAPER | PATENT OWNER |
Patent Owner's Power of Attorney | Dec 10, 2021 | PAPER | PATENT OWNER |
Notice: Notice filing date accorded | Nov 29, 2021 | PAPER | BOARD |
Bausch's Power of Attorney | Oct 22, 2021 | PAPER | PETITIONER |
Petition for Inter Partes Review of U.S. Patent No. 10,307,384 | Oct 22, 2021 | PAPER | PETITIONER |
U.S. Patent No. 10,307,384 | Oct 22, 2021 | EXHIBIT | PETITIONER |
File History for U.S. Patent No. 10,307,384 | Oct 22, 2021 | EXHIBIT | PETITIONER |
Provisional Application No. 60/453,522 | Oct 22, 2021 | EXHIBIT | PETITIONER |
Provisional Application No. 60/435,522 | Oct 22, 2021 | EXHIBIT | PETITIONER |
Transaction History for Provisional Application No. 60/435,522 | Oct 22, 2021 | EXHIBIT | PETITIONER |
Status of Provisional Application No. 60/435,522 | Oct 22, 2021 | EXHIBIT | PETITIONER |
Excerpt of File History for U.S. Patent No. 9,192,586 | Oct 22, 2021 | EXHIBIT | PETITIONER |
FAO, Tocopherol Concentrate, Mixed, U.N. (1986) | Oct 22, 2021 | EXHIBIT | PETITIONER |
WO 2001/019383 (Lang) | Oct 22, 2021 | EXHIBIT | PETITIONER |
U.S. Patent No. 6,582,721 | Oct 22, 2021 | EXHIBIT | PETITIONER |
WO 2003/063848 (Barker) | Oct 22, 2021 | EXHIBIT | PETITIONER |
U.S. Patent No. 5,747,544 (Garnett) | Oct 22, 2021 | EXHIBIT | PETITIONER |
WO 2002/047493 | Oct 22, 2021 | EXHIBIT | PETITIONER |
Nicholas A. Phelps Brown et al., Nutrition supplements and the eye, 12 EYE 127 (1998) (Brown) | Oct 22, 2021 | EXHIBIT | PETITIONER |
D. Max Snodderly, Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins, 62(suppl) AM. J. CLIN. NUTR. 1448S (1995) | Oct 22, 2021 | EXHIBIT | PETITIONER |
Takashi Maoka et al., The First Isolation of Enantiomeric and Meso-Zeaxanthin in Nature, 83B COMP. BIOCHEM. PHYSIOL. 121 (1986) | Oct 22, 2021 | EXHIBIT | PETITIONER |
Jeff C. Evans et al., Optimal Tocopherol Concentrations to Inhibit Soybean Oil Oxidation, 79 J. OF THE AM. OIL CHEMISTS' SOC'Y 47 (2002) | Oct 22, 2021 | EXHIBIT | PETITIONER |
Michael McGuffin & Anthony L. Young, Premarket Notifications of New Dietary Ingredients - A Ten-Year Review, 59 FOOD & DRUG L.J. 229 (2004) | Oct 22, 2021 | EXHIBIT | PETITIONER |
Hall Affidavit, with Authenticated U.S. FDA 95S-0316 75-Day Premarket Notification for New Dietary Ingredient for Zeaxanthin (Report 96) and Web Access Links Attached | Oct 22, 2021 | EXHIBIT | PETITIONER |
Excerpt (Exh. B) of Exh. 1019 - Authenticated U.S. FDA 95S-0316 75-Day Premarket Notification for New Drug Ingredient for Zeaxanthin (Report 96) | Oct 22, 2021 | EXHIBIT | PETITIONER |
Joachim Paust, Technical Syntheses, in 2 CAROTENOIDS 259 (George Britton et al. eds., 1996) | Oct 22, 2021 | EXHIBIT | PETITIONER |
THE MERCK INDEX: AN ENCYCLOPEDIA OF CHEMICALS, DRUGS, AND BIOLOGICALS (Maryadele J. O'Neil et al. eds., 13th ed. 2001) (Excerpt) | Oct 22, 2021 | EXHIBIT | PETITIONER |
FAO, Zeaxanthin: Chemical and Technical Assessment (CTA), U.N. (2004) | Oct 22, 2021 | EXHIBIT | PETITIONER |
Declaration of Elizabeth J. Johnson, Ph.D. with CV | Oct 22, 2021 | EXHIBIT | PETITIONER |
Third Amended Complaint (D.I. 192), ZeaVision, LLC v. Roche Vitamins, Inc., C.A. No. 4:03-CV-00212-DJS (E.D. Mo. Mar. 23, 2004) | Oct 22, 2021 | EXHIBIT | PETITIONER |
Roche Vitamins launched Zeaxanthin as an ingredient to support eye health, NAT. PRODUCTS INSIDER, Aug. 20, 2001 | Oct 22, 2021 | EXHIBIT | PETITIONER |
Anita M. Van der Hagen, et al., Free Radicals and Antioxidant Supplementation: A Review of Their Roles in Age-Related Macular Degeneration, 64 J. AM. OPTOMETRIC ASS'N 871 (1993) | Oct 22, 2021 | EXHIBIT | PETITIONER |
Johanna M. Seddon, et al., Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration, 272 J. OF AM. MED. ASS'N 1413 (1994) | Oct 22, 2021 | EXHIBIT | PETITIONER |
Norman I. Krinsky, et al., Biologic Mechanisms of the Protective Role of Lutein and Zeaxanthin in the Eye, 23 ANN. REV. NUTR. 171 (2003) | Oct 22, 2021 | EXHIBIT | PETITIONER |
Thomas G. Guilliams, ed., Free Radicals, Antioxidants and Eye Diseases, 2 THE STANDARD (1999) | Oct 22, 2021 | EXHIBIT | PETITIONER |
WEBSTER'S NINTH NEW COLLEGIATE DICTIONARY (9th ed. 1991) (Excerpt) | Oct 22, 2021 | EXHIBIT | PETITIONER |
AREDS Report No. 8, 119 ARCH OPHTHALMOLOGY 1417 (2001) | Oct 22, 2021 | EXHIBIT | PETITIONER |
AREDS Report No. 9, 119 ARCH OPHTHALMOLOGY 1439 (2001) | Oct 22, 2021 | EXHIBIT | PETITIONER |
Elizabeth J. Johnson, et al., Nutritional Manipulation of Primate Retinas, III: Effects of Lutein or Zeaxanthin Supplementation on Adipose Tissue and Retina of Xanthophyll-Free Monkeys, 46 INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCI. 692 (2005) | Oct 22, 2021 | EXHIBIT | PETITIONER |
E. Herrera & C. Barbas, Vitamin E: Action, Metabolism and Perspectives, 57 J. PHYSIOL. BIOCHEM. 43 (2001) | Oct 22, 2021 | EXHIBIT | PETITIONER |
ZeaVision, LLC v. Bausch & Lomb Inc., No. 4:21-cv-00739 (E.D. Mo.), D.I. 7 (First Amended Complaint) | Oct 22, 2021 | EXHIBIT | PETITIONER |